Depression and Anxiety States of Patients Followed in Pituitary Polyclinic
Objective: Individuals with pituitary disease are susceptible to the development of depression and anxiety because of interventional therapies, such as surgery and radiotherapy (RT), and long-term medical care (due to hyper or hypofunction). The aim of this study was to assess the quality of life, d...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2024-01-01
|
| Series: | Gazi Medical Journal |
| Subjects: | |
| Online Access: | https://gazimedj.com/articles/depression-and-anxiety-states-of-patients-followed-in-pituitary-polyclinic/doi/gmj.galenos.2023.3724 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841525430673211392 |
|---|---|
| author | Afruz Babayeva Mehmet Muhittin Yalçın Atakan Tüm Aydın Tuncer Sel Alev Eroğlu Altınova Müjde Aktürk Mehmet Ayhan Karakoç İlhan Yetkin Füsun Törüner |
| author_facet | Afruz Babayeva Mehmet Muhittin Yalçın Atakan Tüm Aydın Tuncer Sel Alev Eroğlu Altınova Müjde Aktürk Mehmet Ayhan Karakoç İlhan Yetkin Füsun Törüner |
| author_sort | Afruz Babayeva |
| collection | DOAJ |
| description | Objective: Individuals with pituitary disease are susceptible to the development of depression and anxiety because of interventional therapies, such as surgery and radiotherapy (RT), and long-term medical care (due to hyper or hypofunction). The aim of this study was to assess the quality of life, depression, and anxiety levels of patients in remission from different etiologies of pituitary pathology and to determine the impact of this condition on the disease, treatment approach, and other factors.
Methods: The Beck Depression and Anxiety Inventory was administered to sixty patients and thirty healthy individuals. The parameters of the patient group, including the etiology of pituitary pathology, surgical and radiotherapeutic history, hormonal failure status, and replacement therapy, were recorded.
Results: The patient group’s depression and anxiety scores were significantly higher than those of the control group. In the patient group, there was no significant difference in depression and anxiety levels between those who underwent surgery and those who did not, and between those who received RT and those who did not. Furthermore, depending on pituitary adenoma functionality [functional pituitary adenoma and non-functional pituitary adenoma], hormonal secretion type (growth hormone excess, prolactin hormone excess, cortisol hormone excess, etc.), and hormone replacement treatment. There was no significant difference between the levels of depression and anxiety.
Conclusion: In our study, the presence of pituitary disease due to any etiology was associated with elevated levels of depression and anxiety. Our findings that patients with pituitary adenomas had increased levels of depression and anxiety may have implications for the long-term care of these patients. Although well-being in terms of pituitary illness is ensured in the follow-up of these patients, an effort should be made to reduce depression and anxiety. Comprehensive mental evaluation and psychotherapy should be incorporated into the treatment plan if necessary. |
| format | Article |
| id | doaj-art-068729ae87744efbb4cf39994dde6b6b |
| institution | Kabale University |
| issn | 2147-2092 |
| language | English |
| publishDate | 2024-01-01 |
| publisher | Galenos Publishing House |
| record_format | Article |
| series | Gazi Medical Journal |
| spelling | doaj-art-068729ae87744efbb4cf39994dde6b6b2025-01-17T11:38:13ZengGalenos Publishing HouseGazi Medical Journal2147-20922024-01-01351424610.12996/gmj.galenos.2023.3724Depression and Anxiety States of Patients Followed in Pituitary PolyclinicAfruz Babayeva0https://orcid.org/0000-0002-3482-541XMehmet Muhittin Yalçın1https://orcid.org/0000-0002-1041-6881Atakan Tüm2Aydın Tuncer Sel3https://orcid.org/0000-0003-4188-2823Alev Eroğlu Altınova4https://orcid.org/0000-0002-6707-7761Müjde Aktürk5https://orcid.org/0000-0003-0457-6560Mehmet Ayhan Karakoç6https://orcid.org/0000-0002-0601-6893İlhan Yetkin7Füsun Törüner8https://orcid.org/0000-0002-6168-937XGazi University Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, TürkiyeGazi University Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, TürkiyeGazi University Faculty of Medicine, Ankara, TürkiyeGazi University Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, TürkiyeGazi University Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, TürkiyeGazi University Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, TürkiyeGazi University Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, TürkiyeGazi University Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, TürkiyeGazi University Faculty of Medicine, Department of Endocrinology and Metabolism, Ankara, TürkiyeObjective: Individuals with pituitary disease are susceptible to the development of depression and anxiety because of interventional therapies, such as surgery and radiotherapy (RT), and long-term medical care (due to hyper or hypofunction). The aim of this study was to assess the quality of life, depression, and anxiety levels of patients in remission from different etiologies of pituitary pathology and to determine the impact of this condition on the disease, treatment approach, and other factors. Methods: The Beck Depression and Anxiety Inventory was administered to sixty patients and thirty healthy individuals. The parameters of the patient group, including the etiology of pituitary pathology, surgical and radiotherapeutic history, hormonal failure status, and replacement therapy, were recorded. Results: The patient group’s depression and anxiety scores were significantly higher than those of the control group. In the patient group, there was no significant difference in depression and anxiety levels between those who underwent surgery and those who did not, and between those who received RT and those who did not. Furthermore, depending on pituitary adenoma functionality [functional pituitary adenoma and non-functional pituitary adenoma], hormonal secretion type (growth hormone excess, prolactin hormone excess, cortisol hormone excess, etc.), and hormone replacement treatment. There was no significant difference between the levels of depression and anxiety. Conclusion: In our study, the presence of pituitary disease due to any etiology was associated with elevated levels of depression and anxiety. Our findings that patients with pituitary adenomas had increased levels of depression and anxiety may have implications for the long-term care of these patients. Although well-being in terms of pituitary illness is ensured in the follow-up of these patients, an effort should be made to reduce depression and anxiety. Comprehensive mental evaluation and psychotherapy should be incorporated into the treatment plan if necessary.https://gazimedj.com/articles/depression-and-anxiety-states-of-patients-followed-in-pituitary-polyclinic/doi/gmj.galenos.2023.3724pituitary diseasespituitary adenomahypopituarismquality of lifedepressionanxiety |
| spellingShingle | Afruz Babayeva Mehmet Muhittin Yalçın Atakan Tüm Aydın Tuncer Sel Alev Eroğlu Altınova Müjde Aktürk Mehmet Ayhan Karakoç İlhan Yetkin Füsun Törüner Depression and Anxiety States of Patients Followed in Pituitary Polyclinic Gazi Medical Journal pituitary diseases pituitary adenoma hypopituarism quality of life depression anxiety |
| title | Depression and Anxiety States of Patients Followed in Pituitary Polyclinic |
| title_full | Depression and Anxiety States of Patients Followed in Pituitary Polyclinic |
| title_fullStr | Depression and Anxiety States of Patients Followed in Pituitary Polyclinic |
| title_full_unstemmed | Depression and Anxiety States of Patients Followed in Pituitary Polyclinic |
| title_short | Depression and Anxiety States of Patients Followed in Pituitary Polyclinic |
| title_sort | depression and anxiety states of patients followed in pituitary polyclinic |
| topic | pituitary diseases pituitary adenoma hypopituarism quality of life depression anxiety |
| url | https://gazimedj.com/articles/depression-and-anxiety-states-of-patients-followed-in-pituitary-polyclinic/doi/gmj.galenos.2023.3724 |
| work_keys_str_mv | AT afruzbabayeva depressionandanxietystatesofpatientsfollowedinpituitarypolyclinic AT mehmetmuhittinyalcın depressionandanxietystatesofpatientsfollowedinpituitarypolyclinic AT atakantum depressionandanxietystatesofpatientsfollowedinpituitarypolyclinic AT aydıntuncersel depressionandanxietystatesofpatientsfollowedinpituitarypolyclinic AT aleveroglualtınova depressionandanxietystatesofpatientsfollowedinpituitarypolyclinic AT mujdeakturk depressionandanxietystatesofpatientsfollowedinpituitarypolyclinic AT mehmetayhankarakoc depressionandanxietystatesofpatientsfollowedinpituitarypolyclinic AT ilhanyetkin depressionandanxietystatesofpatientsfollowedinpituitarypolyclinic AT fusuntoruner depressionandanxietystatesofpatientsfollowedinpituitarypolyclinic |